We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.12B
1-Year Est. Return 13.38%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+13.38%
3 Year Est. Return
+70.33%
5 Year Est. Return
+92.94%
10 Year Est. Return
+482.74%
AUM
$2.71B
AUM Growth
+$42.3M
Cap. Flow
+$81.7M
Cap. Flow %
3.02%
Top 10 Hldgs %
18.81%
Holding
318
New
12
Increased
97
Reduced
58
Closed
22

Top Sells

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$33.7M
2
NXPI icon
NXP Semiconductors
NXPI
+$9.76M
3
APH icon
Amphenol
APH
+$8.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$6.42M
5
HDB icon
HDFC Bank
HDB
+$6.31M

Sector Composition

Rank Sector Weight
1 Technology 28.82%
2 Industrials 19.65%
3 Healthcare 17.09%
4 Consumer Discretionary 11.14%
5 Financials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
1
Teledyne Technologies
TDY
$30.4B
$73M 2.7%
226,800
+2,000
+0.9% +$597K
HEI icon
2
HEICO Corp
HEI
$48.9B
$56.3M 2.08%
450,899
+34,100
+8% +$4.66M
WCN
3
Waste Connections
WCN
$42.8B
$52.5M 1.94%
571,125
+51,300
+10% +$4.74M
ANSS
4
DELISTED
Ansys
ANSS
$51.4M 1.9%
232,000
+18,000
+8% +$3.79M
MTD icon
5
Mettler-Toledo International
MTD
$26.8B
$48.4M 1.79%
68,700
+5,500
+9% +$4.04M
ROP icon
6
Roper Technologies
ROP
$36.3B
$47.7M 1.76%
133,700
+4,700
+4% +$1.71M
IDXX icon
7
Idexx Laboratories
IDXX
$42.9B
$47.4M 1.75%
174,200
-2,300
-1% -$640K
FISV
8
Fiserv Inc
FISV
$27.2B
$45.5M 1.68%
439,400
+26,000
+6% +$2.65M
TTC icon
9
Toro Company
TTC
$8.93B
$45M 1.66%
614,300
-18,200
-3% -$1.3M
DHR icon
10
Danaher
DHR
$135B
$42.5M 1.57%
332,309
+82,457
+33% +$10.3M
TDG icon
11
TransDigm Group
TDG
$69.2B
$40.6M 1.5%
78,000
+5,900
+8% +$3.03M
CHD icon
12
Church & Dwight Co
CHD
$23.1B
$38.4M 1.42%
509,700
+38,000
+8% +$2.88M
ACN icon
13
Accenture
ACN
$89.9B
$37M 1.37%
192,300
+24,500
+15% +$4.74M
CRM icon
14
Salesforce
CRM
$134B
$36.5M 1.35%
246,000
+11,000
+5% +$1.67M
AMZN icon
15
Amazon
AMZN
$2.5T
$36.5M 1.35%
420,000
ECL icon
16
Ecolab
ECL
$75.6B
$36.2M 1.33%
182,600
+20,900
+13% +$4.19M
MA icon
17
Mastercard
MA
$477B
$35.5M 1.31%
130,900
+5,000
+4% +$1.38M
CHE icon
18
Chemed
CHE
$6.78B
$34.2M 1.26%
81,900
+8,700
+12% +$3.55M
BALL icon
19
Ball Corp
BALL
$17B
$33.3M 1.23%
457,600
+45,200
+11% +$3.37M
NOW icon
20
ServiceNow
NOW
$102B
$32.5M 1.2%
640,500
+36,000
+6% +$1.96M
TMO icon
21
Thermo Fisher Scientific
TMO
$211B
$32.2M 1.19%
110,600
+39,500
+56% +$11.3M
ROL icon
22
Rollins
ROL
$18.6B
$31.6M 1.16%
1,389,450
AME icon
23
Ametek
AME
$55.5B
$30.8M 1.14%
335,350
-3,000
-0.9% -$265K
TJX icon
24
TJX Companies
TJX
$170B
$28.2M 1.04%
506,600
-28,400
-5% -$1.55M
ALXN
25
DELISTED
Alexion Pharmaceuticals
ALXN
$26.7M 0.98%
272,200
+10,000
+4% +$1.13M

Similar funds

EULAV Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, EULAV Asset Management held 318 positions worth $2.71B, up 1.6% from $2.67B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

EULAV Asset Management deployed $81.7M of net new capital in Q3 2019, opening 12 new positions and adding to 97 existing holdings. Its largest new stake was CrowdStrike: 584,000 shares worth $8.51M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amphenol, an estimated $8.2M trimmed.

  • EULAV Asset Management's largest Q3 2019 buy was CrowdStrike: 584,000 shares worth $8.51M.
  • EULAV Asset Management added most to Automatic Data Processing in Q3 2019, an estimated $12.7M increase.
  • EULAV Asset Management's biggest Q3 2019 reduction was Amphenol, cutting an estimated $8.2M.
  • EULAV Asset Management fully exited Amarin Corp in Q3 2019, selling an estimated $33.7M.
  • EULAV Asset Management's ten largest holdings make up 19% of its $2.71B portfolio in Q3 2019.
  • EULAV Asset Management opened 12 new positions and closed 22 in Q3 2019.
  • EULAV Asset Management's portfolio value rose 1.6% quarter-over-quarter to $2.71B.

Based on EULAV Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.